5-113513942-G-T

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001345975.2(YTHDC2):​c.-243G>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000138 in 1,452,740 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

YTHDC2
NM_001345975.2 5_prime_UTR_premature_start_codon_gain

Scores

1
1
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.18
Variant links:
Genes affected
YTHDC2 (HGNC:24721): (YTH N6-methyladenosine RNA binding protein C2) This gene encodes a member of the DEAH (Asp-Glu-Ala-His) subfamily of proteins, part of the DEAD (Asp-Glu-Ala-Asp) box family of RNA helicases. The encoded protein binds to N6-methyladenosine, a common modified RNA nucleotide that is enriched in the stop codons and 3' UTRs of eukaryotic messenger RNAs. Binding of proteins to this modified nucleotide may regulate mRNA translation and stability. This gene may be associated with susceptibility to pancreatic cancer in human patients, and knockdown of this gene resulted in reduced proliferation in a human liver cancer cell line. [provided by RefSeq, Sep 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.17306969).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
YTHDC2NM_022828.5 linkuse as main transcriptc.47G>T p.Gly16Val missense_variant 1/30 ENST00000161863.9 NP_073739.3 Q9H6S0

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
YTHDC2ENST00000161863.9 linkuse as main transcriptc.47G>T p.Gly16Val missense_variant 1/301 NM_022828.5 ENSP00000161863.4 Q9H6S0
YTHDC2ENST00000515883.5 linkuse as main transcriptc.47G>T p.Gly16Val missense_variant 1/171 ENSP00000423101.1 D6RA70
YTHDC2ENST00000503857.5 linkuse as main transcriptn.47G>T non_coding_transcript_exon_variant 1/165 ENSP00000426644.1 D6RF50

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
0.00000138
AC:
2
AN:
1452740
Hom.:
0
Cov.:
31
AF XY:
0.00000139
AC XY:
1
AN XY:
721820
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000227
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
9.02e-7
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJan 30, 2024The c.47G>T (p.G16V) alteration is located in exon 1 (coding exon 1) of the YTHDC2 gene. This alteration results from a G to T substitution at nucleotide position 47, causing the glycine (G) at amino acid position 16 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.083
T
BayesDel_noAF
Benign
-0.36
CADD
Benign
16
DANN
Benign
0.96
DEOGEN2
Benign
0.0075
T;T
Eigen
Benign
-0.36
Eigen_PC
Benign
-0.29
FATHMM_MKL
Benign
0.66
D
LIST_S2
Benign
0.76
T;T
M_CAP
Benign
0.068
D
MetaRNN
Benign
0.17
T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
0.34
N;.
PrimateAI
Pathogenic
0.88
D
PROVEAN
Benign
-0.55
N;N
REVEL
Benign
0.080
Sift
Uncertain
0.029
D;D
Sift4G
Benign
0.20
T;T
Polyphen
0.21
B;.
Vest4
0.31
MutPred
0.15
Loss of relative solvent accessibility (P = 0.0676);Loss of relative solvent accessibility (P = 0.0676);
MVP
0.043
MPC
0.12
ClinPred
0.50
D
GERP RS
3.6
Varity_R
0.096
gMVP
0.48

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr5-112849639; API